Wan Chen

Wan Chen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2024 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
YYYounan Yao
Younan Yao
BWBo Wang
Bo Wang
TGTian Geng
Tian Geng
JCJiyan Chen
Jiyan Chen
WCWan Chen
Wan Chen
LLLiwen Li
Liwen Li
Background: The prognostic value of triglyceride-glucose (TyG) index in general type 2 diabetes mellitus (T2DM) patients is still unclear. Therefore, we aimed to determine the associations between TyG and all-cause/cause-specific death in a T2DM cohort and explore whether such associations would be modified by age. Methods: A total of 3,376 patients with T2DM from the National Health and Nutrition Examination Survey (NHANES) 1999–2018 were selected and divided into the younger group (< 65 yrs) and the older group (≥ 65 yrs). Baseline TyG was calculated and cause-specific mortality status [cardiovascular (CV), cancer, and non-CV] was determined by the NHANES Public-Use Linked Mortality Files through 31 December 2019. Multivariate Cox and restricted cubic spline (RCS) regression models were used to evaluate the association between TyG and all-cause/cause-specific mortality. Interaction between TyG and age to mortality was also evaluated. Sensitivity analyses were performed in patients without cardiovascular disease, chronic kidney disease, or insulin treatment. Results: During a median follow-up of 107 months, 805 all-cause deaths occurred, of which 250 and 144 were attributed to CV and cancer deaths. There was a significant age interaction to the association between TyG and all-cause/non-CV mortality. After fully adjusting for potential confounding factors, higher TyG was associated with an increased risk of all-cause [TyG per unit increase Hazard Ratio (HR) 1.33, 95% Confidence Interval (CI) 1.06–1.66, p = 0.014] and non-CV mortality (TyG per unit increase HR 1.54, 95% CI 1.18–2.01, p = 0.002) only in the younger group, but not in the older group. There was no significant association between TyG and CV/cancer death in the total cohort and two age subgroups. Similar results were found in RCS and sensitivity analyses. Conclusion: In a national sample of patients with T2DM in the United States, we found that the association between TyG and all-cause/non-CV death was modified by age. Higher TyG was only associated with an increased risk of all-cause/non-CV only in T2DM patients younger than 65 years old, but not in older patients.

13 August 2026 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
XDXu Deng
Xu Deng
XXXixiang Xie
Xixiang Xie
XZXing Zhou
Xing Zhou
LJLanfang Jiang
Lanfang Jiang
TZTao Zhu
Tao Zhu
CCChunxia Chen
Chunxia Chen
The therapeutic efficacy of ischemic stroke (IS) treatment is severely limited by insufficient accumulation of therapeutic agents within ischemic lesions a

26 August 2026 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
ZQZhenyan Qin
Zhenyan Qin
YZYingying Zhang
Yingying Zhang
SLSuyun Liu
Suyun Liu
ZLZhe Li
Zhe Li
JLJiayu Li
Jiayu Li
LLLiwen LYU
Liwen LYU
Optimal timing for urinary catheter removal in intensive care unit (ICU) patients remains challenging, as conventional static measurements often fail to ac